American Journal of Advanced Drug Delivery Open Access

  • ISSN: 2321-547X
  • Journal h-index: 22
  • Journal CiteScore: 9.36
  • Journal Impact Factor: 5.76
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Research Article - (2021) Volume 9, Issue 6

Development and Validation Of RP- HPLC Method for the Estimation of Imiquimod in Pharmaceutical Dosage Forms

Visit for more related articles at American Journal of Advanced Drug Delivery

Abstract

A reverse phase liquid chromatography (RP-HPLC) method has been developed and subsequently validated for the determination of Imiquimod. Separation was achieved with a cosmosil C18, 250 mm × 4.6 mm I.D; particle size 5 μm) Column and pH 4.6 phosphate buffer and Acetonitrile (20:80) v/v as mobile phase at a flow rate of 0.8 mL/min and the Column temperature was maintained at 25°C. UV detection was performed at 244 nm with a run time of 10 min. The method is simple, rapid, and selective. The described method of imiquimod is linear over a range of 5 ng/ mL to 600 ng/mL and with correlation coefficient of 0.992 respectively. The method precision for the determination of assay was below 2.0% RSD. The method enables accurate, precise, and rapid analysis of imiquimod.